title: Modulation of interleukin-12 mRNA expression in leukocytes of cancer patients treated with CM101.
authors.affiliation: Vanderbilt University School of Medicine, Nashville, Tennessee 37232-0146, USA.
authors.forename: C G
authors.initials: CG
authors.lastname: Hellerqvist
authors.forename: R S
authors.initials: RS
authors.lastname: Lloyd
authors.forename: E
authors.initials: E
authors.lastname: Wang
authors.forename: S
authors.initials: S
authors.lastname: Bardhan
mesh_terms: D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D018664:Interleukin-12 / Q000235:genetics*; D007958:Leukocyte Count / Q000187:drug effects; D011135:Polysaccharides, Bacterial / Q000627:therapeutic use*; D012333:RNA, Messenger / Q000235:genetics; D018123:Receptors, Interleukin / Q000235:genetics; D053707:Receptors, Interleukin-12; D013997:Time Factors
chemical_list: D011135:Polysaccharides, Bacterial; D012333:RNA, Messenger; D018123:Receptors, Interleukin; D053707:Receptors, Interleukin-12; C032263:streptococcal polysaccharide type III group B; D018664:Interleukin-12